Generex Biotechnology Corporation, through its subsidiary, Hema Diagnostic Systems, LLC, focuses on the development, manufacture, and distribution of in-vitro medical diagnostics for infectious diseases in Canada and the United States. The company offers Rapid Diagnostic Tests for human immunodeficiency virus?½ w/p24Ab, tuberculosis-XT, malaria, hepatitis, syphilis, typhoid, dengue, and other infectious diseases. Generex Biotechnology Corporation was founded in 1983 and is based in Miramar, Florida.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:GNBT
CUSIPN/A
Phone416-364-2551
Debt
Debt-to-Equity RatioN/A
Current Ratio0.07
Quick Ratio0.07
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash Flow$19.6429 per share
Price / Cash0.14
Book Value($74.78) per share
Price / Book-0.04
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-70,010,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-166.13%
Miscellaneous
Employees12
Outstanding Shares1,070,000
Market Cap$2.63
Generex Biotechnology (OTCMKTS:GNBT) Frequently Asked Questions
What is Generex Biotechnology's stock symbol?
Generex Biotechnology trades on the OTCMKTS under the ticker symbol "GNBT."
When is Generex Biotechnology's next earnings date?
What is the consensus analysts' recommendation for Generex Biotechnology?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Generex Biotechnology in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Who are some of Generex Biotechnology's key competitors?
Some companies that are related to Generex Biotechnology include Mabvax Therapeutics (MBVX), ContraVir Pharmaceuticals (CTRV), Amarillo Biosciences (AMAR), Soligenix, Inc. Common Stock (SNGX), iCo Therapeutics (ICOTF), Sunwin Stevia International (SUWN), Jaguar Health (JAGX), International Stem Cell (ISCO), Uluru (ULUR), Concordia International (CXRXF), Concordia International (CXRX), Apricus Biosciences (APRI), ERBA Diagnostics (ERBA), MYOS Co. common stock (MYOS) and Reliv International (RELV).
Who are Generex Biotechnology's key executives?
Generex Biotechnology's management team includes the folowing people:
- Mr. Joseph Moscato, CEO, Pres & Chairman (Age 54)
- Mr. Mark Corrao, CFO & Treasurer (Age 59)
- Mr. Andrew Ro, Chief Investment Officer, Sr. VP of Investments & Director (Age 47)
- Mr. Mark A. Fletcher Esq., Exec. VP, Gen. Counsel & Sec. (Age 53)
- Mr. Richard D. Purcell, Sr. VP of Research & Drug Devel. (Age 57)
Has Generex Biotechnology been receiving favorable news coverage?
Headlines about GNBT stock have trended somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Generex Biotechnology earned a news sentiment score of 0.18 on Accern's scale. They also gave news stories about the company an impact score of 45.10 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Generex Biotechnology?
Shares of GNBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Generex Biotechnology's stock price today?
One share of GNBT stock can currently be purchased for approximately $2.75.
How big of a company is Generex Biotechnology?
Generex Biotechnology has a market capitalization of $2.63 million. Generex Biotechnology employs 12 workers across the globe.
How can I contact Generex Biotechnology?
Generex Biotechnology's mailing address is 10102 USA TODAY WAY, MIRAMAR FL, 33025. The company can be reached via phone at 416-364-2551 or via email at [email protected]
MarketBeat Community Rating for Generex Biotechnology (OTCMKTS GNBT)
MarketBeat's community ratings are surveys of what our community members think about Generex Biotechnology and other stocks. Vote "Outperform" if you believe GNBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
